Target General Information
Target ID	T46128
Target Name	Melanocyte protein PMEL
Synonyms	ME20M; ME20S; Mbeta; Melanocyte protein PMEL; Melanocyte protein Pmel 17; Melanomaassociated ME20 antigen; P1; P100; Premelanosome protein; Silver locus protein homolog; PMEL
Target Type	Clinical Trial
Gene Name	PMEL
Biochemical Class	PMEL/NMB family
UniProt ID	PMEL_HUMAN
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals
Disease	Melanoma
Example drug	Melanoma vaccine			Phase 3	[521514], [1572592]
Tissue	Skin
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual	Fold-change: 1.89 Z-score: 1.06 P-value: 1.08E-03
Target gene expression profiles of the patients in the disease section of the tissue Target gene expression profiles in the tissue of healthy individual Download target gene expression data of the patients in the disease section of the tissue Download target gene expression data in the tissue of healthy individual
Target Gene Expression Profiles in Other Tissues of Healthy Individuals
Download the Expression Profile (Genomics. 86(2):127-41, 2005)
Reference
Ref 521514	ClinicalTrials.gov (NCT00036816) Vaccine Therapy in Treating Patients With Melanoma of the Eye. U.S. National Institutes of Health.
Ref 1572592	NCBI GEO: archive for functional genomics data sets--update.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.